260 related articles for article (PubMed ID: 23440352)
1. Adiponectin increases glucose-induced insulin secretion through the activation of lipid oxidation.
Patané G; Caporarello N; Marchetti P; Parrino C; Sudano D; Marselli L; Vigneri R; Frittitta L
Acta Diabetol; 2013 Dec; 50(6):851-7. PubMed ID: 23440352
[TBL] [Abstract][Full Text] [Related]
2. Expression of fatty acid binding proteins 3 and 5 genes in rat pancreatic islets and INS-1E cells: regulation by fatty acids and glucose.
Hyder A; Zenhom M; Klapper M; Herrmann J; Schrezenmeir J
Islets; 2010; 2(3):174-84. PubMed ID: 21099311
[TBL] [Abstract][Full Text] [Related]
3. Berberine inhibits glucose oxidation and insulin secretion in rat islets.
Bai M; Liu Y; Zhou F; Zhang Y; Zhu Q; Zhang L; Zhang Q; Wang S; Zhu K; Wang X; Zhou L
Endocr J; 2018 Apr; 65(4):469-477. PubMed ID: 29467344
[TBL] [Abstract][Full Text] [Related]
4. Pioglitazone acutely reduces insulin secretion and causes metabolic deceleration of the pancreatic beta-cell at submaximal glucose concentrations.
Lamontagne J; Pepin E; Peyot ML; Joly E; Ruderman NB; Poitout V; Madiraju SR; Nolan CJ; Prentki M
Endocrinology; 2009 Aug; 150(8):3465-74. PubMed ID: 19406947
[TBL] [Abstract][Full Text] [Related]
5. Adiponectin counteracts cytokine- and fatty acid-induced apoptosis in the pancreatic beta-cell line INS-1.
Rakatzi I; Mueller H; Ritzeler O; Tennagels N; Eckel J
Diabetologia; 2004 Feb; 47(2):249-58. PubMed ID: 14722646
[TBL] [Abstract][Full Text] [Related]
6. Beta cell compensation for insulin resistance in Zucker fatty rats: increased lipolysis and fatty acid signalling.
Nolan CJ; Leahy JL; Delghingaro-Augusto V; Moibi J; Soni K; Peyot ML; Fortier M; Guay C; Lamontagne J; Barbeau A; Przybytkowski E; Joly E; Masiello P; Wang S; Mitchell GA; Prentki M
Diabetologia; 2006 Sep; 49(9):2120-30. PubMed ID: 16868750
[TBL] [Abstract][Full Text] [Related]
7. Globular adiponectin augments insulin secretion from pancreatic islet beta cells at high glucose concentrations.
Gu W; Li X; Liu C; Yang J; Ye L; Tang J; Gu Y; Yang Y; Hong J; Zhang Y; Chen M; Ning G
Endocrine; 2006 Oct; 30(2):217-21. PubMed ID: 17322583
[TBL] [Abstract][Full Text] [Related]
8. Adiponectin reduces glucotoxicity-induced apoptosis of INS-1 rat insulin-secreting cells on a microfluidic chip.
Lin P; Chen L; Li D; Liu J; Yang N; Sun Y; Xu Y; Fu Y; Hou X
Tohoku J Exp Med; 2009 Jan; 217(1):59-65. PubMed ID: 19155609
[TBL] [Abstract][Full Text] [Related]
9. Adiponectin is functionally active in human islets but does not affect insulin secretory function or beta-cell lipoapoptosis.
Staiger K; Stefan N; Staiger H; Brendel MD; Brandhorst D; Bretzel RG; Machicao F; Kellerer M; Stumvoll M; Fritsche A; Häring HU
J Clin Endocrinol Metab; 2005 Dec; 90(12):6707-13. PubMed ID: 16204361
[TBL] [Abstract][Full Text] [Related]
10. Metformin restores insulin secretion altered by chronic exposure to free fatty acids or high glucose: a direct metformin effect on pancreatic beta-cells.
Patanè G; Piro S; Rabuazzo AM; Anello M; Vigneri R; Purrello F
Diabetes; 2000 May; 49(5):735-40. PubMed ID: 10905481
[TBL] [Abstract][Full Text] [Related]
11. Chronic palmitate exposure inhibits AMPKalpha and decreases glucose-stimulated insulin secretion from beta-cells: modulation by fenofibrate.
Sun Y; Ren M; Gao GQ; Gong B; Xin W; Guo H; Zhang XJ; Gao L; Zhao JJ
Acta Pharmacol Sin; 2008 Apr; 29(4):443-50. PubMed ID: 18358090
[TBL] [Abstract][Full Text] [Related]
12. Long term exposure to fatty acids and ketones inhibits B-cell functions in human pancreatic islets of Langerhans.
Zhou YP; Grill V
J Clin Endocrinol Metab; 1995 May; 80(5):1584-90. PubMed ID: 7745004
[TBL] [Abstract][Full Text] [Related]
13. NAD(P)H oxidase participates in the palmitate-induced superoxide production and insulin secretion by rat pancreatic islets.
Graciano MF; Santos LR; Curi R; Carpinelli AR
J Cell Physiol; 2011 Apr; 226(4):1110-7. PubMed ID: 20857410
[TBL] [Abstract][Full Text] [Related]
14. Lipid rather than glucose metabolism is implicated in altered insulin secretion caused by oleate in INS-1 cells.
Segall L; Lameloise N; Assimacopoulos-Jeannet F; Roche E; Corkey P; Thumelin S; Corkey BE; Prentki M
Am J Physiol; 1999 Sep; 277(3):E521-8. PubMed ID: 10484365
[TBL] [Abstract][Full Text] [Related]
15. Glucose-induced repression of PPARalpha gene expression in pancreatic beta-cells involves PP2A activation and AMPK inactivation.
Ravnskjaer K; Boergesen M; Dalgaard LT; Mandrup S
J Mol Endocrinol; 2006 Apr; 36(2):289-99. PubMed ID: 16595700
[TBL] [Abstract][Full Text] [Related]
16. Physiological concentrations of interleukin-6 directly promote insulin secretion, signal transduction, nitric oxide release, and redox status in a clonal pancreatic β-cell line and mouse islets.
da Silva Krause M; Bittencourt A; Homem de Bittencourt PI; McClenaghan NH; Flatt PR; Murphy C; Newsholme P
J Endocrinol; 2012 Sep; 214(3):301-11. PubMed ID: 22761278
[TBL] [Abstract][Full Text] [Related]
17. Induction of uncoupling protein 2 mRNA in beta-cells is stimulated by oxidation of fatty acids but not by nutrient oversupply.
Li LX; Skorpen F; Egeberg K; Jørgensen IH; Grill V
Endocrinology; 2002 Apr; 143(4):1371-7. PubMed ID: 11897694
[TBL] [Abstract][Full Text] [Related]
18. Impaired insulin secretion by diphenyleneiodium associated with perturbation of cytosolic Ca2+ dynamics in pancreatic beta-cells.
Imoto H; Sasaki N; Iwase M; Nakamura U; Oku M; Sonoki K; Uchizono Y; Iida M
Endocrinology; 2008 Nov; 149(11):5391-400. PubMed ID: 18617620
[TBL] [Abstract][Full Text] [Related]
19. Glucolipotoxicity promotes the capacity of the glycerolipid/NEFA cycle supporting the secretory response of pancreatic beta cells.
Oberhauser L; Jiménez-Sánchez C; Madsen JGS; Duhamel D; Mandrup S; Brun T; Maechler P
Diabetologia; 2022 Apr; 65(4):705-720. PubMed ID: 35018486
[TBL] [Abstract][Full Text] [Related]
20. Peroxisome proliferator-activated receptor alpha (PPARalpha) potentiates, whereas PPARgamma attenuates, glucose-stimulated insulin secretion in pancreatic beta-cells.
Ravnskjaer K; Boergesen M; Rubi B; Larsen JK; Nielsen T; Fridriksson J; Maechler P; Mandrup S
Endocrinology; 2005 Aug; 146(8):3266-76. PubMed ID: 15878969
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
